Skip to main content

Global Blood Therapeutics — Deal History & Benchmarks

Total Deals
2
Across 1 therapeutic area
Total Deal Value
$10.8B
Cumulative transaction value
Most Active Year
2022
2 deals closed
Primary TA
Hematology
100% of deal activity
Model Your Deal

Market Analysis

Global Blood Therapeutics has been involved in 2 transactions totaling $10.8B across Hematology. As both a licensor and licensee, they have demonstrated an active acquisition strategy.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Global Blood Therapeutics done?
Global Blood Therapeutics has completed 2 verified transactions tracked in our database, spanning from 2022 to 2022. These deals have a combined value of $10.8B.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Related Benchmarks

Hematology Deal Benchmarks

View

Small Molecule Deals

View

Phase 2 Deal Benchmarks

View

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating